Clinical trials for Stargardt disease
16 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07425574A Study to Learn How Stargardt-type Eye Conditions Progress in Children and AdultsAstellas Pharma Global Development, Inc. · PI: Medical Director
- RECRUITINGPHASE1, PHASE2NCT07439887Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt DiseaseRay Therapeutics, Inc.
- RECRUITINGPhase 1NCT07417566A Study of DC6001 Tablet in Healthy Chinese Adult SubjectsHeronova Pharmaceuticals
- RECRUITINGPHASE1, PHASE2NCT07161544A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)AAVantgarde Bio Srl
- RECRUITINGPHASE1, PHASE2NCT06942572A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)Splice Bio
- RECRUITINGNCT06445322Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)Ascidian Therapeutics, Inc · PI: Alia Rashid
- RECRUITINGPHASE1, PHASE2NCT06467344Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)Ascidian Therapeutics, Inc · PI: Alia Rashid
- RECRUITINGNCT06591806An Observational Study in Children and Adults With Stargardt DiseaseAAVantgarde Bio Srl
- RECRUITINGNCT06435000An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 GeneSplice Bio
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06300476Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)West China Hospital · PI: Fang Lu, MD
- ACTIVE NOT RECRUITINGNCT06048185Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT StudyNanoscope Therapeutics Inc. · PI: Dr. Samarendra Mohanty
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05956626A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseOcugen · PI: Murthy Chavali, MD, Ph.D.
- ACTIVE NOT RECRUITINGNCT05674058Function and Imaging Assessments for G1961E-associated Stargardt DiseaseUniversity Hospital, Basel, Switzerland
- RECRUITINGPHASE1, PHASE2NCT04545736Oral Metformin for Treatment of ABCA4 RetinopathyNational Eye Institute (NEI) · PI: Brian P Brooks, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT04239625Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)Alkeus Pharmaceuticals, Inc.
- ENROLLING BY INVITATIONPhase 2NCT02402660Phase 2 Tolerability and Effects of ALK-001 on Stargardt DiseaseAlkeus Pharmaceuticals, Inc.